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A B S T R A C T
IMPLICATIONS ANDPurpose: The aim of the studywas to investigate the association between serum uric acid (SUA) and
cardiovascular risk classes (CRCs) in adolescents using a cluster-based approach.
Methods: A cross-sectional evaluation was carried out in the 2007e2008 school year, including
adolescents born in 1990 and enrolled in the schools of Porto, Portugal. The analysis included 1,286
adolescents. To identify CRC, a normal mixture model was performed including several biological
cardiovascular risk factors. A multinomial logistic regression model was applied to explore the
association between SUA and each CRC.
Results: Three classes were extracted using model-based cluster analysis (low, medium, and high
CRC). The high CRC accounted for the smallest proportion of participants (5.6%) and represented
the adolescents with higher waist circumference, systolic and diastolic blood pressures, total
cholesterol, triglycerides, and insulin levels. Adolescents at increased risk of cardiovascular disease
had signiﬁcantly higher mean concentrations of SUA compared with adolescents at low cardio-
vascular risk (55.0 vs. 51.5 mg/L in males and 41.9 vs. 37.6 mg/L in females). After adjustment and
considering low CRC as reference, SUA was positively associated with high CRC in both sexes (odds
ratio, 1.04; 95% conﬁdence interval, 1.00e1.07 in males; and odds ratio, 1.04; 95% conﬁdence in-
terval, 1.01e1.07 in females).
Conclusions: Among 17-year-old adolescents, SUA increases were positively associated with higher
CRC.
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Previous studies have
shown strong associations
between serum uric acid
and cardiovascular dis-
eases in adults. Serum uric
acid was positively associ-
ated with high cardiovas-
cular risk class in
adolescents. To our knowl-
edge, the association of
SUA and cardiovascular
risk factor clustering, using
data-driven approach, has
not been evaluated in prior
studies.Adolescence is a generally healthy periodwhen important behav-
ioral patterns are developed and preventable biological risk factors
such as high blood pressure, high blood cholesterol, and overweight
underlie cardiovascular disease (CVD) and other chronic diseases [1].
Serum uric acid (SUA) is the end product of the metabolism
of purine compounds. Previous studies have suggested that
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associated with deleterious effects on endothelial function,
platelet adhesion and aggregation, and oxidative metabolism
[2,3].
Elevated SUA has frequently been described as a correlate of
the development and progression of CVD. Several cohort
studies have shown positive and signiﬁcant associations between
SUA and CVDs in adult population [4,5]. Systematic reviews and
meta-analyses have also conﬁrmed this association [6,7].
Although CVD generally occurs in adulthood, the process of
atherosclerosis can begin in childhood [8]. Previous cross-
sectional data have shown a close relationship between SUA
concentrations and cardiovascular (CV) risk factors in children
and adolescents [9]. Findings from a cohort study of adolescents
from Taiwan showed that adolescents with hyperuricemia have
an increased risk of mortality, especially because of kidney and
CVDs [10]. However, the speciﬁc role of SUA in the development
of CVD remains unclear among adults and even more so among
children and adolescents. In a young population, mostly free of
chronic disorders, it would be helpful to use data-driven
approach to better deﬁne how CV risk factors tend to cluster in
adolescence and their association with SUA.
The aim of the study was to investigate the association be-
tween SUA and CV risk in adolescents, using a cluster-based
approach to identify those at high CV risk.
Methods
Subjects
This study was developed as part of the EPITeen study, a
cohort of adolescents born in 1990 and attending public and
private schools in Porto, Portugal [11]. Recruitment of the cohort
took place during the 2003e2004 school year when adolescents
were 13 years old, and 2,160 (77.7% from public schools and 76.7%
from private schools, p ¼ .710) agreed to participate by providing
information for at least part of the planned protocol.
During the 2007e2008 school year, the ﬁrst follow-up was
performed using the same protocol and 1,716 (79.4%) of the
participants were reevaluated. Additionally, 783 adolescents
who were born in 1990 but did not attend school in the Porto
area at baseline were evaluated for the ﬁrst time.
A cross-sectional analysis was carried out including 1,286 17-
year-old adolescents with complete information on anthropo-
metrics and blood samples.
Data collection
The evaluation included self-administered questionnaires,
comprising information on social, demographic, and behavioral
characteristics and individual and family history of CVD.
Sports activity was considered as practicing some sports,
outside the compulsory school curriculum, independently of the
frequency or intensity.
Adolescents were classiﬁed regarding their use of alcohol and
tobacco as never users if they have never drunk alcoholic drinks
and if they have never smoked. If they reported only experi-
mented those substances, either occasionally or regularly, they
were classiﬁed as ever drinkers or smokers, respectively.
A physical examination was also performed at school, by a
team of experienced nurses, nutritionists, and physicians.
Anthropometrics was obtained with the subjects in light indoorclothes and no shoes. Weight was measured using a Tanita bio-
impedance scale (Tanita TBF-300; Tanita Corporation of America,
Inc., Arlington Heights, IL) with subjects positioned in the center
of the weighing platform so that their weight was evenly
distributed. Height was measured with a portable stadiometer,
with subjects standing with their heels together and their head
positioned in the Frankfort horizontal plane, with heels, but-
tocks, shoulder blades, and head against the back of the stadi-
ometer. Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters (kg/m2).
Waist circumference (WC) was measured to the nearest
centimeter, midway between the lower limit of the rib cage and
the iliac crest, with the subject standing, using a ﬂexible and
nondistensible tape, and avoiding pressure on the tissues [12].
Blood pressure was measured with a mercury sphygmoma-
nometer using the auscultatory method, following the recom-
mendations of the American Academy of Pediatrics [13]. We
considered the mean of two readings taken on a single occasion,
separated by at least 10 minutes of rest, with a third reading
being taken if the difference between the ﬁrst two readings was
greater than 5 mm Hg.
A 12-hour overnight fasting blood sample was drawn from
consenting participants. Blood was centrifuged, serum and
plasma were divided into aliquots, and immediately analyzed or
stored frozen at80C until used. SUA, glucose, total cholesterol,
high-density lipoprotein cholesterol (HDLc), and triglycerides
were measured using standard automatic routine enzymatic
methods in use at the central pathology laboratory of the
University Hospital of São João, Porto.
The homeostasis model assessment (HOMA) was used to
calculate indices of insulin resistance and insulin secretion for
each patient. The HOMA Calculator v2.2.2 (Diabetes Trials Unit,
University of Oxford, Oxford, UK) used fasting glucose and in-
sulin to generate the index of insulin resistance (HOMA2-IR) [14].
Ethical considerations
Written informed consent was obtained from adolescents and
legal guardians. The study protocol complied with the Declara-
tion of Helsinki andwas approved by the Ethics Committee of the
University Hospital of São João in Porto, Portugal.
Statistical analysis
Quantitative continuous variables according to sex-speciﬁc
SUA quartiles and CRCs were compared using one-way analysis
of variance. Categorical variables were compared using the
chi-square test.
Pearson correlation analysis was used to examine the relation-
ship between biological CV risk variables (systolic blood pressure
[SBP], diastolic blood pressure [DBP], BMI, WC, HDLc, total choles-
terol, triglycerides, glucose, insulin, and HOMA2-IR). For variables
highly correlated (Pearson coefﬁcient  .800), only one was
included in the cluster analysis performed to identify CRCs [15].
Model-based clustering is based on the assumption that the
observed data come from a population consisting of several sub-
populations. Using this analysis, cluster solutions are not affected
by changes in a variable’s unit of measurement when dealing with
normal distributions with unknown variances. For this reason, we
did not standardize the variables by each standard deviation unit.
To the cluster analyses, the number of classes was deﬁned
according to the Bayesian information criterion [16].
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explore the association between SUA and each CRC. Statistical
testing of the linearity assumption was performed.
Statistical analysis was performed using the R Statistical
Software (version 2.7.1, R Foundation for Statistical Computing,
Austria).
Results
Comparisons between adolescents with and without follow-
up revealed only differences for alcohol consumption and
sports practice. Final sample participants practice sports more
often and have lower proportion of current drinkers in female
adolescents. For smoking, age at menarche, WC, SBP, and DBP,
there were no differences between groups.
Characteristics of the participants according to sex-speciﬁc
SUA quartiles are summarized in Table 1. BMI, WC, insulin, andTable 1
Descriptive analysis of EPITeen cohort adolescents aged 17 years according to sex-spe
SUA, mg/L (N ¼ 1,286)
Q1, n ¼ 325 Q2, n ¼ 322
Female 32.8 >32.8e37.7
Male 46.2 >46.2e52.2
Smoking (ever smokers); n (%)
\ 75 (43.4) 78 (46.2)
_ 62 (41.1) 66 (44.3)
Alcohol (ever drinkers); n (%)
\ 139 (80.3) 132 (78.1)
_ 127 (84.7) 132 (89.3)
Sports practice (yes); n (%)
\ 70 (41.9) 75 (45.7)
_ 104 (71.2) 109 (74.1)
Age at menarche (years); mean (SD)
\ 12.31 (1.19) 12.36 (1.42)
_ d d
Body mass index (kg/m2); mean (SD)
\ 21.92 (2.89) 21.61 (2.62)
_ 21.69 (3.00) 21.96 (3.01)
Waist circumference (cm); mean (SD)
\ 74.06 (7.53) 73.67 (7.36)
_ 76.01 (7.24) 77.09 (7.74)
Triglycerides (g/L); mean (SD)
\ .70 (.30) .74 (.33)
_ .64 (.24) .65 (.31)
Total cholesterol (g/L); mean (SD)
\ 1.68 (.31) 1.70 (.29)
_ 1.46 (.25) 1.47 (.27)
HDLc (g/L); mean (SD)
\ .60 (.12) .60 (.12)
_ .52 (.10) .52 (.11)
SBP (mm Hg); mean (SD)
\ 112.56 (10.16) 112.59 (10.82)
_ 119.86 (12.87) 119.26 (13.01)
DBP (mm Hg); mean (SD)
\ 67.76 (8.42) 66.14 (8.64)
_ 70.00 (9.63) 68.77 (9.43)
Glucose (g/L); mean (SD)
\ .83 (.07) .84 (.08)
_ .87 (.08) .87 (.15)
Insulin (mIU/mL); mean (SD)
\ 6.00 (3.56) 5.39 (3.59)
_ 5.29 (3.23) 4.95 (3.08)
HOMA2-IR; mean (SD)
\ .76 (.45) .69 (.45)
_ .69 (.41) .64 (.40)
DBP ¼ diastolic blood pressure; HDLc ¼ high-density lipoprotein cholesterol; HOMA2
pressure; SD ¼ standard deviation.HOMA2-IR means tended to increase with increasing quartiles of
SUA concentrations in both males and females. This trend was
also observed for triglycerides and total cholesterol in males.
HDLc mean decreased with increasing categories of SUA inmales.
The correlations between the biological CV risk factors
analyzed in this study were performed to decide the ﬁnal vari-
ables to include in the cluster models. As expected, a strong
correlation between insulin and HOMA2-IR (Pearson coefﬁcient:
.999, p < .001) and between WC and BMI (Pearson coefﬁcient:
.844, p < .001) was observed, and for that reason only, WC and
insulin were considered in the ﬁnal model-based clustering. For
all the other variables, correlation coefﬁcients were lower than .5.
Considering data on SBP, DBP, WC, HDLc, total cholesterol,
triglycerides, glucose, and insulin, three CRCs were extracted
using model-based cluster analysis.
Table 2 provides the description of the three CRCs (low, me-
dium, and high). The low CV risk ﬁrst accounted for the largestciﬁc serum uric acid (SUA) quartiles, by sex (Porto, Portugal 2007e2008)
p value
Q3, n ¼ 317 Q4, n ¼ 322
>37.7e43.2 >43.2
>52.2e58.0 >58.0
70 (42.2) 79 (46.5) .823
59 (40.1) 60 (40.5) .883
138 (84.7) 137 (81.1) .496
126 (85.7) 127 (84.7) .528
80 (49.1) 67 (40.6) .401
104 (72.2) 109 (75.2) .870
12.19 (1.29) 12.34 (1.38) .622
d d d
22.34 (3.01) 23.51 (4.36) .001
22.50 (3.10) 24.32 (3.85) .001
74.77 (7.45) 77.24 (10.09) .001
78.64 (7.64) 82.72 (10.
32)
.001
.76 (.37) .73 (.32) .491
.66 (.28) .73 (.35) .045
1.71 (.33) 1.72 (.36) .710
1.55 (.28) 1.52 (.27) .011
.59 (.11) .57 (.13) .059
.51 (.10) .47 (.09) .001
112.92 (12.81) 111.75 (10.39) .794
118.56 (11.48) 120.40 (12.49) .610
66.96 (8.99) 67.22 (8.15) .361
70.83 (9.67) 70.40 (9.63) .277
.82 (.08) .83 (.07) .452
.86 (.08) .88 (.08) .621
5.48 (3.83) 6.51 (4.89) .038
6.15 (5.25) 6.36 (4.65) .008
.69 (.48) .83 (.60) .036
.79 (.66) .82 (.57) .009
-IR ¼ homeostasis model assessment of insulin resistance; SBP ¼ systolic blood
Table 2
Characterization of classes with low, medium, and high cardiovascular (CV) risk
identiﬁed in the EPITeen cohort adolescents aged 17 years, by sex (Porto, Portugal
2007e2008)
CV risk classes (N ¼ 1,286) p value
Low (n ¼ 769) Medium (n ¼ 445) High (n ¼ 72)
Female 383 270 29
Male 386 175 43
Waist circumference (cm); mean (SD)
\ 72.86 (6.12) 76.8 (9.47) 84.7 (10.30) .001
_ 75.78 (5.57) 82.00 (9.99) 90.33 (11.18) .001
Triglycerides (g/L); mean (SD)
\ .57 (.13) .89 (.31) 1.38 (.67) .001
_ .54 (1.34) .85 (.28) 1.09 (.57) .001
Total cholesterol (g/L); mean (SD)
\ 1.63 (.26) 1.77 (.33) 2.07 (.50) .001
_ 1.45 (.22) 1.55 (.30) 1.77 (.34) .001
HDLc (g/L); mean (SD)
\ .59 (.11) .59 (.13) .59 (.13) .479
_ .52 (.10) .47 (.11) .49 (.10) .001
SBP (mm Hg); mean (SD)
\ 111.62 (10.94) 112.99 (9.90) 118.45 (18.83) .003
_ 118.79 (11.94) 118.46 (10.79) 130.44 (17.65) .001
DBP (mm Hg); mean (SD)
\ 66.60 (8.13) 67.02 (8.35) 72.69 (13.10) .001
_ 60.30 (8.77) 69.93 (8.26) 76.56 (16.89) .001
Glucose (g/L); mean (SD)
\ .83 (.08) .83 (.07) .82 (.08) .454
_ .86 (.08) .88 (.07) .93 (.26) .001
Insulin (mIU/mL); mean (SD)
\ 4.16 (2.14) 7.26 (3.49) 15.00 (8.27) .001
_ 4.25 (2.09) 7.26 (3.50) 12.13 (9.44) .001
DBP ¼ diastolic blood pressure; HDLc ¼ high-density lipoprotein cholesterol;
SBP ¼ systolic blood pressure; SD ¼ standard deviation.
Figure 1. Mean and 95% conﬁdence interval (CI) of serum uric acid (mg/L)
according to cardiovascular (CV) risk classes by sex.
Table 3
Association between serum uric acid (mg/L) and cardiovascular (CV) risk classes,
by sex (N ¼ 1,286), based on multinomial logistic regression analysis
CV risk classes
Low Medium High
OR (95% CI) OR (95% CI) OR (95% CI)
Male
Crude model 1 1.03 (1.01e1.05) 1.04 (1.00e1.07)
Adjusted modela 1 1.03 (1.01e1.05) 1.04 (1.00e1.07)
Female
Crude model 1 1.02 (1.00e1.04) 1.06 (1.02e1.11)
Adjusted modelb 1 1.03 (1.01e1.05) 1.04 (1.01e1.07)
Low CV risk class is the reference category.
CI ¼ conﬁdence interval; OR ¼ odds ratio.
a Adjusted for smoking (current smoker), alcohol (current drinker), and sports
practice (yes/no).
b Adjusted for smoking (current smoker), alcohol (current drinker), sports
practice (yes/no), and age at menarche (years).
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adolescents (males and females) with lower SBP, DBP, WC,
cholesterol, triglycerides, and insulin levels. Adolescent males in
this subgroup also had lower glucose and higher HDLc levels. On
the other hand, the high CRC accounted for the smallest
proportion of participants (5.6%) and represents the adolescents
with higher SBP, DBP, WC, cholesterol, triglycerides, and insulin
levels. Adolescentmales in this subgroup had signiﬁcantly higher
glucose levels. Increasing the CRC, it is notorious that the
biological variables’ means also increases (except for HDL). No
signiﬁcant differences were found between CRCs regarding
smoking, alcohol, and physical activity (data not shown).
The SUAvalues ranged from12.1 to 86.4mg/L (_: 13.2e86.4; \:
12.1e68.5), with amean of 52.6mg/L (9.9) inmales and 38.2mg/L
(8.2) in females. The SUAmean values according to CRC by sex are
presented graphically in Figure 1. In both genders, adolescents at
increased risk of CVD had higher mean values of SUA.
Considering low CRC as reference, there is a signiﬁcant pos-
itive relationship between SUA and medium and high CRCs in
both sexes (Table 3). The relationship between SUA and CRCs is
linear. In univariated analysis, the odds ratio for the association
between SUA and high CRC was 1.04 (95% conﬁdence interval,
1.00e1.07) in males and 1.06 (95% conﬁdence interval, 1.02e1.11)
in females. After adjustment, each SUA (mg/L) unit increase was
associated with a 4% increased odds of high CV risk, in both
sexes.
Discussion
The present study showed that SUA is positively associated
with high CRC among adolescents.Previous cross-sectional data have shown a close relationship
between SUA concentrations and individual CV risk factors in
children and adolescents [9,17]. A study in the U.S. children and
adolescents shows that concentrations of SUA were signiﬁcantly
associated with abdominal obesity, hypertriglyceridemia, low
HDL, high blood pressure, and hyperglycemia. The strongest
association was between SUA and abdominal obesity [9].
Detection of high-risk individuals is reliable by CVD risk
clusters approach because CV risk factors tend to cluster and
work synergistically [1,18]. As WC is widely used as a proxy
measure of visceral adiposity, it was included in cluster-based
model instead of BMI. Insulin and HOMA have been used as IR
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HOMA has been reported in pediatric studies [19]. Considering
that fasting insulin is a biological variable mandatory to generate
HOMA and both were highly correlated, the inclusion of insulin
in cluster analysis was an obvious option [20].
Clustering of CV risk factors have been previously docu-
mented among adolescents [21,22]. To our knowledge, the as-
sociation of SUA and CV risk factors clustering, using data-driven
approach, has not been evaluated in prior studies.
Model-based cluster analysis seems to be a valuable and
adequate analytic tool for research in CV diseases. It can be used
to explore heterogeneous population to better integrate
distinctive processes into a consistent conceptual framework and
also as an alternative method for comparing groups when the
assumption of measurement invariance is either untenable or
unreasonable across different populations.
Using a model-based cluster analysis, three classes were
extracted (low, medium, and high CRCs). The participant distri-
bution for each class is based on similarity attending eight
different physiological CV risks. The descriptive analysis revealed
higher biological CV risk factors and lower HDLc means for the
high CV class. A total of 73 adolescents (5.6%) were grouped on
the highest CRC (class 3). This class probably represents the
adolescents with metabolic syndrome (MS). In the present
sample, using the de Ferranti criteria [23], theMS prevalencewas
6.3% (data not shown). Similar prevalence for adolescents was
described in Brazilian and North American populations [24,25]. A
systematic review of literature brought evidence that the prev-
alence of MS among adolescents varied from 2.2% to 52.1%
depending on the criterion adopted and the studied population
[26]. The variation of MS prevalence among studies is essentially
explained by the existence of several adolescent deﬁnitions
[27,28].
In the present study, high CRC seems to represent mainly the
adolescents with adiposity and insulin resistance. Some studies
showed that SUA level is independently associated with serum
leptin level and suggested that leptin could be a factor respon-
sible for hyperuricemia in obese patients [29] and with insulin
resistance syndrome [30]. In a study of a 14-year-old population,
high adiposity was the strongest independent predictor of
inﬂammatory markers, accounting for 28% of variance in uric
acid [31]. There is evidence of a common pathway underlying
insulin resistance, obesity, and lipid production. Obesity may be
linked to decreased glucose tolerance and hyperinsulinemia [32].
Adipocytes can increase the production of free fatty acids and
slow down glucose uptake stimulating hepatic glucose produc-
tion and suppressing pancreatic insulin secretion [33]. Moreover,
increased lipid production by the liver is associated with an
overall increase in total glucose production, additional stress on
beta cell function, and insulin production [34].
Gender differences in SUA concentrations were observed.
Females had lower SUA mean in all CRCs. Other studies reported
gender differences in the normal SUA levels [35,36]. This differ-
ence becomes most obvious during adolescence and has been
attributed to the effect of estrogen. However, the magnitude of
association between SUA and high CV risk did not differ by sex.
This study has several strengths and limitations. Its strengths
include the use of large, population-based sample from a 17-
year-old adolescents cohort enrolled in public and private
schools. Participants with missing information or who were lost
to follow-up were excluded. Comparisons between adolescents
with and without follow-up revealed only differences for alcoholconsumption and sports practice. Final sample is more physically
active with lower proportion of female drinkers indicating a
possible selection of healthier participants. Hypothesizing a
possible interference between SUA and CV classes associations, it
is certainly an underestimation and not overestimation of the
real association.
A limitation of the study was the relatively small sample size
in the high CV risk group. Even so, a signiﬁcant positive associ-
ation between SUA and high CRC was found. The errors attrib-
uted to self-report information in school-based adolescent
health surveys, even in those anonymous, are usually mentioned
as a possible limitation because they could lead to an underes-
timation of exposure and outcome. However, in the present
study, the main exposure and outcome were objectively
assessed, which constitutes the strength of the study. Moreover,
data were collected by trained interviewers. The cross-sectional
nature of our data does not allow us to discern the causal
relationships. So, we are unable to identify if SUA increase leads
to higher CRC or if it occurs in the opposite way. Further longi-
tudinal studies would be useful to clarify the independent role of
high SUA in CV adolescent’s health and how these various risk
factors interact over time.
The present study described that SUA was positively associ-
ated with higher CRC, in a population cohort of 17-year-old
adolescents. The study supports that the relation between SUA
levels and CV risk factors clustering appears to be established
early in the life course.
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